Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.
about
Mammalian collagen IVHuman alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growthMolecular pathways: niches in metastatic dormancyHeat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity.Validation of Different Systems for Tumstatin Expression and its in-vitro and iv-vivo Activities.Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cellsRegulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivoEnzymatic processing of collagen IV by MMP-2 (gelatinase A) affects neutrophil migration and it is modulated by extracatalytic domains.Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV networkImpact of the non-cellular tumor microenvironment on metastasis: potential therapeutic and imaging opportunities.Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis.Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3.Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope.DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
P2860
Q28265884-B8E486EF-EBDE-4802-8FB6-243A957A3B00Q28271413-9A9E60C8-DA5D-4F46-A156-14413BD6559AQ33798648-DF221AE8-7332-4109-9189-D814F536B910Q33838536-AC351D0D-DA4E-4AB4-8432-90DBC9107FDDQ33876100-D3EF0199-5CB5-4F45-B956-1C565C4854AEQ34102845-8955E2C9-1BD6-4968-9F55-F0A302448989Q35902328-6145855D-170E-4DC8-B40F-9A5C45AF8F60Q35925032-2DAAE4F7-485F-4C66-923D-44650ADEBFC9Q36178061-0C0B62F8-40F4-4D50-BA87-53A3B966D162Q36458187-C83F6248-1FEA-432E-B69C-56799FD36DF7Q36666850-9871D2F8-4F51-4517-8CE5-727774F1FCFAQ36893780-C4088FCD-0EAB-406B-9D9C-7A504717C169Q36922699-46B2E959-06F6-4F9B-B5EF-236805F0039CQ37380604-BBB8ADE8-D937-4895-BC92-E656A405B95EQ37401941-93879BFB-2275-45FC-A46A-2BE1A08DA7B2Q40274571-5C4EF333-B01D-4CC8-B756-814D46FE95D4Q42735424-8B661F29-67E5-44A1-8AEC-CC37A4C9B2E9Q54387117-CCAD21BA-8BBD-4224-B78E-D2766710552D
P2860
Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Recombinant alpha2(IV)NC1 doma ...... inhibits tumor growth in vivo.
@ast
Recombinant alpha2(IV)NC1 doma ...... inhibits tumor growth in vivo.
@en
type
label
Recombinant alpha2(IV)NC1 doma ...... inhibits tumor growth in vivo.
@ast
Recombinant alpha2(IV)NC1 doma ...... inhibits tumor growth in vivo.
@en
prefLabel
Recombinant alpha2(IV)NC1 doma ...... inhibits tumor growth in vivo.
@ast
Recombinant alpha2(IV)NC1 doma ...... inhibits tumor growth in vivo.
@en
P2093
P2860
P1476
Recombinant alpha2(IV)NC1 doma ...... inhibits tumor growth in vivo.
@en
P2093
Abebe Akalu
Anat Zelmanovich
Desiree Policarpio
Jennifer M Roth
Leonard Liebes
Peter C Brooks
Shannon MacDonald
Silvia Formenti
P2860
P304
P356
10.1016/S0002-9440(10)62310-3
P407
P577
2005-03-01T00:00:00Z